More than one-third of postmenopausal women estimate their risk of ovarian cancer to be at least 50%.
Researchers have found a link between higher dietary fiber intake and lower risk of colorectal adenoma.
Researchers found a complete response for 94.4% of women with locally advanced cervical cancer treated with erlotinib and cisplatin-based chemoradiation.
Individuals with a history of nonmelanoma skin cancer (NMSC) have an increased risk of subsequent primary cancers.
A group of researchers discovered a promising new approach to treating leukemia by disarming a gene responsible for tumor progression.
Most residents agree that care coordination could improve chronic disease management.
Final rule relating to HIPAA allows a patient or personal representative to access results directly from the laboratory.
A new model of care has been proposed where physicians focus on patients while team members perform other functions.
Changes in health insurance coverage can change adherence to preventive care, but does not impact health behaviors in general.
Mass cancellations of physicians in Medicare Advantage plans in many states prompts protests.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
Patients cite treatment description by the treating physician as the most helpful source.
Researchers found an unexpected, aberrant accumulation of esterified cholesterol in human PCa tissue.
At 18 years of follow-up, patients who underwent radical surgery had a decreased risk of cancer-related and all-cause mortality.
Elevated urinary levels of the organic compound were found in men with prostate cancer than in those without it.
Alvimopan also was found to shorten hospital length of stay.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|